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ABSTRACT
A great deal of controversy surrounds e-cigarettes, with some arguing that
protection of youth and non-users is paramount and others maintaining that these products are
beneficial from a harm reduction perspective for use by adult smokers for switching from
combustible cigarettes and for smoking cessation. Opponents of e-cigarettes have allocated
tremendous funds toward advertising campaigns aimed at youth deterrence; however, to date, the
effects of these ads upon adult smokers have yet to be examined. The current study used a
between-subjects experimental design to investigate the effects of an FDA-distributed youthtargeted anti-vaping PSA, “Vaping is an Epidemic,” upon adult smokers who view it. The PSA
shows teens vaping and, upon inhalation, parasite-like organisms invading their organs and skin.
We hypothesized that the FDA PSA – compared to a matched control video that was similar in
parasitic activity but absent of e-cigarette content – would increase negative health-related
expectancies, and because the PSA conveys that e-cigarettes are very powerful, it would also
increase expectancies concerning potency. We also hypothesized that the anti-vaping PSA would
impact other general expectancies of e-cigarettes and additional variables reflecting motivation
to quit smoking (i.e., switch to vaping). We found that viewing the PSA produced increases in
both health harm and potency expectancies (ps < .01), which were correlated (p < .001). We also
found significant group differences (ps < .05) such that viewing the PSA resulted in overall more
negative expectancies about e-cigarettes and all other variables related to harm reduction usage.
Those who viewed the PSA rated e-cigarettes as more harmful and less effective compared to
those who saw the control video. Viewing the PSA also resulted in lower switching motivation
v

(i.e., switching from combustible to e-cigarettes). Overall, our findings indicated that adult
smokers who viewed the PSA were less likely to consider e-cigarettes for smoking cessation,
thus reducing access to a cessation aid with growing empirical support. Findings suggest that
youth-oriented anti-vaping messages may have unintended public health consequences upon
adult audiences.
.
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INTRODUCTION
Combustible cigarette smoking is the leading cause of preventable death worldwide
(USDHHS, 2014). In the United States, approximately 14% of adults (age 18 or older) are
smokers; however, 68% of these smokers report wanting to quit (Wang et al., 2018).
Nonetheless, annual cessation success rates for adult smokers remain low — at approximately
7% (CDC, 2017). Results from the National Health Interview Survey, an annual, nationally
representative, in-person survey of the noninstitutionalized U.S. civilian population, showed that
among smokers who were trying to quit, the use of cessation counseling and/or pharmacotherapy
(both nicotine replacement therapy and medications for cessation) increased during 2000–2005
from 21.9% to 29.1%. Findings from the most recent analyses showed that this rate of use of
counseling and/or pharmacotherapy remained generally unchanged from 2005, and has plateaued
entirely from 2010-2015 (CDC, 2017). Overlapping with this plateau, rates of current electronic
cigarette (e-cigarette) use among all adults rose over six-fold from 2010 (0.3-1%) to 2013 (2.66.8%) (King, Patel, Nguyen, & Dube, 2014; McMillen, Gottlieb, Shaefer, Winickoff, & Klein,
2014). Furthermore, the prevalence of current e-cigarette use among adult former smokers rose
significantly from 2014-2016 (3.8-4.8%), whereas there was a significant reduction in e-cigarette
use among adult current smokers during this time frame (15.9-10.8%) (Bao et al., 2018). This
pattern may suggest that e-cigarette use is the means by which a proportion of adults’ transition
from current to former smokers. Furthermore, population-based data showed that the dramatic
increase in e-cigarette use among adult smokers was associated with a statistically significant
increase in the national smoking cessation rate (Zhu et al., 2017).
1

Since the introduction of e-cigarettes and their increasing prevalence, there have been
conflicting viewpoints concerning the impact of these products on both smokers and
nonsmokers, with a strong emphasis on adolescents’ risk. Potential benefits and harms of ecigarettes have been suggested, such as the likely harm-reduction benefits for those who are
unable or unwilling to quit smoking using existing U.S. Food and Drug Administration (FDA)approved cessation methods and/or counseling, along with concerns, such that these products
may pose a threat of nicotine dependence among those who are not otherwise susceptible (e.g.,
Fagerström, Etter, & Unger, 2015). These views have become increasingly polarized as ecigarettes have become both more widespread and substantially more effective at nicotine
delivery and consequent higher dosing (Balfour et al., 2021).

E-Cigarettes
E-cigarettes, which are portable devices that use a battery-powered heating element to
aerosolize liquid for inhalation, come in a variety of types (Brown & Cheng, 2014; Ebbert,
Agunwamba, & Rutten, 2015). Earlier first-generation e-cigarettes are disposable or rechargeable and tend to resemble cigarettes in size and shape. Later second- and third-generation
models vary in appearance due to customizable features; many have no resemblance to cigarettes
whatsoever. These later versions are both rechargeable and refillable, such that they can be filled
with the user’s preferred solution per nicotine content (or lack thereof) and flavor type. Despite
the ability to customize some models, in general, first- through third-generation e-cigarettes have
been shown to be less effective than combustible cigarettes at nicotine delivery, particularly
among novice users (Norton, June, & O'Connor, 2014; Trtchounian, Williams, & Talbot, 2010).
However, in a review, Evans and Hoffman (2014) found that e-cigarette use was generally
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associated with decreased cravings for cigarettes, despite reported deficiencies in nicotine
delivery.
Juul. In 2015, the e-cigarette landscape drastically changed with the launch of Juul
(Huang et al., 2019; Willett et al., 2019), and similar vaping devices. Juul is a closed system
“pod mod” device charged via USB. Juul is marketed as an alternative to combustible cigarettes
and existing e-cigarette devices. Juul works similarly to other e-cigarette devices but has several
features that make it distinctive and more effective at nicotine delivery. First, the Juul device
resembles a USB drive, making it both sleek and easily concealable (Allem, Dharmapuri, Unger,
& Cruz, 2018). Second, in terms of nicotine delivery, the liquid in a Juul “pod” (disposable prefilled cartridge that contains 0.7 ml solution with 5% nicotine by weight) contains protonated
nicotine (“nicotine salt” vs. freebase nicotine typically used in e-cigarettes) that is absorbed at
almost the same rate as nicotine from a combustible cigarette (O’Connell et al., 2019). Moreover,
the aerosol from nicotine salt is reported to produce less subjective irritation in the chest and
lungs, compared to combustible cigarettes (Krishnan-Sarin et al., 2019). Lastly, Juul has more
than twice the nicotine concentration as the majority of e-cigarettes. One Juul pod has
approximately the same amount of nicotine as one pack of cigarettes (from
http://www.Juulvapor. com).
Reasons for e-cigarette use. Juul has transformed into the largest retail e-cigarette brand
in the U.S., thereby elevating sales of the entire e-cigarette category (Huang et al., 2019).
Though studies and surveys have not yet elucidated the likely multifactorial reasons for this fast
growth specific to Juul, past research has shown many reasons for the initiation and maintenance
of e-cigarette use that likely generalize to Juul. Reported reasons for e-cigarette use include: that
they are an alternative to combustible cigarettes (Dawkins, Turner, Roberts, & Soar, 2013); e-
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cigarettes pose reduced health risks compared to cigarettes (Majeed et al., 2017); e-cigarettes
cost less than cigarettes (Patel et al., 2016); and e-cigarettes are more convenient because they
can be used in non-smoking areas (Sears et al., 2017). Furthermore, in a recent study conducted
with adult smokers, among those who had used Juul, the most frequently endorsed reason for use
was, “I was trying to quit smoking cigarettes” (Patel et al., 2019), Notably, independent of the
reported reason for the initiation of use, many e-cigarette users report quitting smoking or
substantially reducing tobacco use after e-cigarette initiation (Caponnetto et al., 2014; Dawkins
et al., 2013; Siegel, Tanwar, & Wood, 2011).
E-cigarettes for Smoking Cessation
In 2019, Juul launched the “Make the Switch” advertising campaign, which features
adults sharing reasons why they made the switch from cigarettes (or other tobacco products) to
Juul. The majority of the advertising budget was allocated to television commercials. Although
the FDA bans e-cigarette companies from purporting that the product is less harmful than
cigarettes or that they are smoking cessation products, Juul conveys an implicit message of
cessation by stating that it is “designed with smokers in mind” and is “for adult smokers seeking
a satisfying alternative to cigarettes” (from http://www.Juulvapor. com).
Although media campaigns implicitly suggest that e-cigarettes are aimed at smoking
cessation, studies directly investigating e-cigarettes for this purpose are limited due to regulatory
issues and limited long-term safety data. Almost all published studies utilized first- or secondgeneration devices. Randomized controlled trials conducted with e-cigarettes have shown that ecigarettes were as effective as nicotine patches (Bullen et al., 2013); that the 1-year abstinence
rate was nearly double with e-cigarettes compared to NRT (Hajek et al., 2019); that e-cigarettes
plus NRT were more effective than NRT alone (Walker et al., 2020); that participants with no
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intention of quitting smoking showed significant smoking reductions following provision of an
e-cigarette (Caponnetto et al., 2014; Polosa et al., 2014); and that smokers who were instructed
and incentivized for complete substitution of cigarettes with e-cigarettes showed significant
reductions in smoking and a nearly double 8-week abstinence rate compared to NRT (Hatsukami
et al., 2019). Additionally, a cohort study found that former smokers who were current vapers
had over three times the smoking abstinence rate at one year follow-up compared to smokers and
dual users who comprised the remainder of the sample (Manzoli et al., 2015). These findings
suggest that e-cigarettes likely are effective for maintaining smoking abstinence and for smoking
reduction and/or cessation. (Hartmann-Boyce et al., 2016; McRobbie, Bullen, Hartmann-Boyce,
& Hajek, 2014).
Notably, almost no studies have been conducted with devices that utilize protonated
nicotine, “nicotine salt.” One small randomized cross-over study (O’Connell et al., 2019) found
that the highest level of salt tested (40 mg) in a closed-system pod device showed a
pharmacokinetic profile most similar to a combustible cigarette. Reported subjective effects were
most favorable following smoking a combustible cigarette followed by vaping the 40 mg salt
solution. The authors conclude that the rapid absorption with a higher plasma concentration
achieved with nicotine salt likely produces greater reductions in desire to smoke; this is thought
to be important for facilitation of both smokers’ switching to e-cigarettes and for relapse
prevention.
Reduced harmfulness of e-cigarettes. In addition to a growing literature suggesting that
e-cigarettes may be effective for smoking cessation (Hajek et al., 2015, 2019; Hartmann-Boyce
et al., 2016; McNeill et al., 2018; McRobbie et al., 2014), there is also considerable evidence
suggesting that e-cigarettes are far less harmful than combustible cigarettes (e.g., Abrams et al,
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2018; Brandon et al., 2015). According to Public Health England and the Royal College of
physicians, e-cigarettes are at least 95% less harmful than traditional cigarettes (McNeill et al.,
2015; Royal College of Physicians, 2016). In 2018, Public Health England reaffirmed their
position that e-cigarettes pose only a fraction of harms compared to smoking; thus, smokers
should be encouraged to switch to e-cigarettes (McNeill et al., 2018). Additionally, an expert
committee of the National Academies of Sciences, Engineering, and Medicine (2018) found
conclusive evidence that completely switching to e-cigarettes reduces users’ exposure to
numerous toxicants and carcinogens found in combustible cigarettes. Furthermore, they found
substantial evidence that completely switching to e-cigarettes results in reduced adverse health
consequences in several organ systems. However, opponents to the proposed helpfulness and
harm-reduction potential of e-cigarettes argue, among other topics, that these devices pose a risk
to youth and never-smokers’ susceptibility to smoking (Berry et al., 2019; Soneji et al., 2018;
Warner & Mendez, 2019). Additionally, Eissenberg et al. (2020) argued against the claim that ecigarettes are 95% safer than cigarettes by suggesting that current devices and liquids have
changed in ways that could induce more harm than previously reported.

Effects of E-cigarette Advertising on Smoking Cessation
A central question of the harm reduction versus adolescent/never-smokers risk debate
concerns whether e-cigarette advertising impacts smoking cessation (Dave et al., 2019). Recent
trends in U.S. smoking rates suggest that increased use of e-cigarettes may be contributing to
reductions in adult smoking; the rate dropped from 20.9% in 2005 to 15.1% in 2015.
Furthermore, during the 2011-2015 period during which data on e-cigarette use are available,
adult smoking reduced by 4.23 percentage points (Dave et al., 2019). Simultaneous with the
surge in e-cigarette use from 2010 (0.3-1%) to 2013 (2.6-6.8%) (King, Patel, Nguyen, & Dube,
6

2014; McMillen, Gottlieb, Shaefer, Winickoff, & Klein, 2014), there was a substantial increase
in e-cigarette advertising expenditures from $3.6M in 2010 to $112M in 2014, with the majority
of spending allocated to magazine and television ads with national reach (Kim, Arnold, &
Makarenko, 2014; Kornfield et al., 2015). As evidence of the effectiveness of e-cigarette
advertising having national reach, in a 2013 sample of Florida residents, approximately 48% of
adults had been exposed to e-cigarette marketing (Kim et al., 2014).
Dave et al. (2019) assert that e-cigarette television advertising plays a causal role in adult
smoking cessation. They conducted a series of mutinominal logit models utilizing data from the
Simmons National Consumer Survey matched to e-cigarette advertising aired on national and
local broadcast and cable stations. The models, which controlled for targeted ads, examined the
probabilities of quitting, failing to quit, and attempting to quit. Their sample (N=8291) mean quit
rate was 9%, which is above the national average of 7%. Their most comprehensive model
showed that exposure to one additional television advertisement (above the mean of three
advertisements) raised the quit probability by 1%, relative to the sample mean quit rate. Due to
the linearity of the models, exposure to five additional ads, for example, would increase the
number of quitters by 5%. Those who quit smoking were exposed to more e-cigarette television
advertisements (on average, 4.5) than those who failed a quit attempt (3.7 advertisements) or
those who did not attempt to quit (2.9 advertisements). Furthermore, television advertising for ecigarettes was associated with increases in cessation attempts using each of four methods
investigated: e-cigarettes only, NRT only, cold turkey, and other (a mixed methods quit attempt).
Those who attempted to quit with the use of e-cigarettes only accounted for the second highest
percentage (24.1%), outnumbered only by “other” (i.e., mixed methods approach, which was
40%). Furthermore, television advertising had no statistically significant impact on the failure
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rate; however, exposure to an additional television advertisement raised the quit attempt
probability by 0.07 marginal percentage points. Dave et al. conclude that a policy banning
television advertising of e-cigarettes (to take effect in August, 2022) would reduce the number of
smokers who quit by 3% (105,000 individuals); whereas, if the FDA were not to enforce a
forthcoming ban on e-cigarette advertising, the number of smokers who quit could increase by
10% (350,000 individuals). These percentages were calculated based on data from 2015; hence,
the percentages could be higher at present.
E-cigarette advertising content. The content of e-cigarette advertisements tends to
include comparative claims regarding combustible cigarettes, such as themes that implicitly
convey that e-cigarettes are a healthier or “smarter” alternative to cigarettes or could be used as a
cessation aide (Haardörfer et al., 2017; Payne et al., 2016; Banerjee et al., 2015). Current FDA
regulations do not permit ads to explicitly state that the products can be used for smoking
cessation or are less harmful than traditional cigarettes; however, Kim et al. (2015) found that
75% of a sample of adult smokers reported that viewing a television ad for e-cigarettes “made
me think about quitting smoking.” Similar to the majority of advertisements for e-cigarettes, the
ad viewed by their sample (http://www.youtube.com/watch?v=tHPU2gR_RiI) for blu ecigarettes conveyed several messages about the superiority of e-cigarettes to traditional
cigarettes, such as e-cigarettes are more convenient/can be used anywhere (and thus avoid
smoking restrictions), come in a variety of flavors, are available in different nicotine strengths,
have no odor or ash, produce vapor (not smoke), cost less, and are a “smarter alternative to
cigarettes.”
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Expectancies
Although Kim et al. (2015) did not propose reasons why the advertisement caused such a
high proportion of viewers to report that it made them think about quitting smoking, the effect
could be mediated by cognitive expectancies. Drug-related expectancies are often considered
within the framework of social learning theories (Bandura, 1977) that suggest individuals hold
both “self-efficacy expectancies” and “outcome expectancies” about their behavior and its
consequences (Brandon, Herzog, Irvin, & Gwaltney, 2004; Brandon, Juliano, & Copeland,
1999). Self-efficacy expectancies incorporate thoughts regarding the ability to accomplish a
behavior, such as quitting smoking.
Outcome expectancies refer to the approximated consequences occasioned by a behavior;
in this case, e-cigarette use. Drug outcome expectancies refer to beliefs about the results of
substance use, and they have been shown to reliably predict behavior (e.g., Brandon, Juliano, &
Copeland, 1999). Outcome expectancies have received more attention in substance use research,
particularly concerning alcohol use, regarding the role of expectancies in the initiation,
maintenance, and cessation of substance use (Goldman, 1999; Goldman, Brown, & Christiansen,
1987; Goldman, Del Boca, & Darkes, 1999). Outcome expectancies are essential to cognitive
models explaining motivational antecedents of substance use behavior (Abrams & Niaura, 1987;
Pokhrel et al., 2014; Brandon, Juliano & Copeland, 1999). Prior to the initiation of substance
use, outcome expectances are thought to develop via observation, including through media
(Leventhal & Schmitz, 2006).
Within the alcohol use literature, outcome expectancies have been studied since the
1970s via balanced-placebo experiments that have shown that many behavioral effects of alcohol
– generally attributed to pharmacological effects – are actually due to outcome expectancies
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(Hull & Bond, 1986; Marlatt, Demming, & Reid, 1973). Within a broader research context of the
“placebo effect,” reviews have concluded that the concepts of expectancy and placebo could be
considered to be interchangeable (Benedetti, Carlino, & Pollo, 2011). Additionally,
expectancies, as measured by psychometric scales, have been shown to predict subsequent
drinking behavior, even in children and adolescents who had never directly experienced alcohol
(Christiansen, Goldman, & Inn, 1982; Christiansen et al., 1989; Colder et al., 2014; Jester et al.,
2014). Furthermore, experiments utilizing random assignment showed that expectancies can be
malleable, with resultant effects on drinking quantities; thus, outcome expectancies also
represent behavioral-control processes (Darkes & Goldman, 1993, 1998; Scott-Sheldon et al.,
2012). In sum, within a larger explanatory framework, outcome expectancies can be viewed as a
future-oriented aspect of substance use motivation (e.g., Benitez & Goldman, 2019; Goldman,
2002).
Smoking expectancies. Outcome expectancies pertaining to combustible cigarette
smoking have been extensively studied. Four types of smoking expectancy constructs have been
previously validated in a college student sample: negative consequences (e.g., health risks),
positive reinforcement/sensory satisfaction (e.g., smoking helps me relax), negative
reinforcement/negative affect reduction (e.g., cigarettes help me deal with depression), and
appetite/weight control (e.g., smoking helps to control my appetite) (Smoking Consequences
Questionnaire [SCQ]; Brandon & Baker, 1991). A follow-up study conducted with nicotinedependent adult smokers revealed a greater number of factors (10) than those four factors found
with college students; this finding suggests that expectancies become more specific with
smoking experience (SCQ-A; Copeland, Quinn, & Brandon, 1995). Similar patterns of
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expectancy differentiation based on age and experience have been found with respect to alcohol
(Brown, Christiansen, & Goldman 1987; Rohsenow, 1983).
E-cigarette expectancies. Pokrel et al. (2014) assessed whether these types of smoking
outcome expectancies generalize to e-cigarettes in a college student sample. They found that
being a current smoker was positively associated with positive e-cigarette expectancies, such that
current smokers were more likely to endorse the following positive e-cigarette expectancies:
social enhancement, affect regulation, and positive sensory expectancies. Additionally, being a
current smoker was negatively associated with the following negative e-cigarette expectancies:
negative health consequences, negative appearance, negative sensory experience, and addiction
concern. Additionally, higher positive expectancies were associated with greater likelihood of
past 30-day use of e-cigarettes. Higher negative expectancies, with the exception of addiction
concern, were associated with lower likelihood of past 30-day e-cigarette use. Among those who
had never used e-cigarettes, positive expectancies were significantly associated with higher
intentions to use e-cigarettes in the future. To date, e-cigarette expectancy studies generally have
been limited to college-aged samples (e.g., Harrell et al., 2019; Pokhrel et al, 2015; Pokhrel et
al., 2018) and studies of adults based on survey findings (Harrell et al., 2015a, 2015b; Piñeiro et
al., 2016).
To investigate e-cigarette expectancies on smoking and vaping urge reduction in adults,
Palmer and Brandon (2018) conducted a balanced-placebo study. They crossed instructional set
(told nicotine/told non-nicotine) with drug dose (nicotine/non-nicotine) to test e-cigarette
expectancies via the placebo effect (i.e., told nicotine/given non-nicotine). They found that,
among dual users of combustible and e-cigarettes, there was a main effect of instructional set on
reductions in craving to smoke cigarettes, with participants who were told that their e-cigarette
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contained nicotine reporting greater craving reduction, independent of whether they received a
nicotine or non-nicotine solution. With respect to reduced cravings for e-cigarettes, they found
an interaction between drug dose and instructional set; as such, nicotine e-cigarettes reduced
cravings more than non-nicotine e-cigarettes only among participants told to expect nicotine.
This study lends support that cognitive expectancies contribute to the acute effects of e-cigarettes
on craving in adults and that e-cigarettes likely have utility for smoking cessation.
Anti-Vaping Media
Although substantial support for the harm reduction potential of e-cigarettes and their use
for effective smoking cessation have been discussed thus far, there are concerns about youth
non-smokers’ susceptibility to e-cigarette use (USDHHS, 2016; Gentzke et al., 2019), along with
some data showing e-cigarette use among youth is associated with initiation and maintenance of
cigarette smoking (Berry et al., 2019; Hartman-Boyce et al., 2016; National Academies of
Science, Engineering, and Math, 2018). Given these concerns and the rapid rise of e-cigarette
use, the FDA responded in 2018 with a $60M anti-vaping media campaign, “The Real Cost
Youth E-Cigarette Prevention Campaign,” geared toward combating what the FDA calls an
“epidemic of youth vaping” (https://www.fda.gov/tobacco-products/public-health-education/realcost-campaign). This ongoing campaign has launched a series of sensationalized advertisements
(and other materials) using scare tactics in an attempt to dissuade youth from using e-cigarettes.
This strategy is based on prior anti-smoking campaigns, such as “Tips from Former Smokers,”
that featured graphic imagery intended to scare teens into quitting smoking.
Potential unintended consequences of anti-vaping campaigns. Public health
campaigns designed to scare youth away from vaping may have unintended consequences for
adults who are exposed to these ads and other materials. Consequently, anti-vaping youth
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campaigns could produce the opposite effects that Dave et al. (2019) and Kim et al. (2015) found
with e-cigarette advertisements, previously shown to increase smoking cessation rates, attempts,
and induce contemplation regarding cessation. These unintended consequences may occur via
modification of adults’ expectancies about e-cigarettes, and the generalization of those
expectancies to other aspects of e-cigarettes, such as their potential for smoking cessation. On
one hand, the negative information about e-cigarettes may lead to generalized negative
expectancies about them, encompassing their efficacy for smoking cessation. It is also possible
that the health warnings about e-cigarettes increase negative expectancies about the harms of ecigarettes, which directly discourages their use for smoking cessation. (i.e., why switch if they
are just as harmful as smoking?). These expectancies may suppress the desire to use e-cigarettes
– and even the efficacy of them – as a smoking cessation aide; including use to cope with urges
to smoke. On the other hand, the information about the dangers of e-cigarettes as conveyed in
the PSA may lead to generalized expectancies about e-cigarette potency, including their potential
efficacy for coping with urges and smoking cessation. As such, these expectancies may increase
the desire to use, and the efficacy of, e-cigarettes. These two possibilities are not necessarily
mutually exclusive. Both types of expectancies could occur, and possibly even cancel each other
out at the end. Alternatively, one type of expectancy may be prepotent with respect to its effect
upon smoking cessation.
The Present Study
To date, there have been no investigations to assess whether anti-vaping campaigns are
even effective at deterring youth from using e-cigarettes. Critically, there also has been no
research investigating unintended consequences of these advertisements upon adult smokers. The
goal of the proposed study was to investigate the effects of an FDA-distributed anti-vaping PSA
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aimed at youth upon adult smokers who view it. In particular, it examined if the PSA —
compared to a neutral control video—produced changes in specific expectancies regarding (1)
negative health harms of vaping and (2) potency of e-cigarettes. Additionally, it examined if the
PSA altered general expectancies about (3) the efficacy of vaping for smoking cessation. We
also assessed downstream dependent variables, including interest in using e-cigarettes to quit
smoking (i.e., switching motivation).

Specific Aims and Hypotheses
Specific Aim 1. Evaluate the effects of an anti-vaping PSA on acute e-cigarette
expectancies, as compared to a neutral, control video
Hypothesis 1.1 Negative media about e-cigarettes will increase negative health-related
expectancies, compared to the control video.
Hypothesis 1.2. Because the advertisement conveys that e-cigarettes are very powerful,
positive expectancies concerning the potency of e-cigarettes will increase, compared to the
control video.
Specific Aim 2 .Evaluate whether the anti-vaping PSA produces changes in other
expectancies relevant to harm reduction, compared to the control video.
Hypothesis 2.1. The anti-vaping PSA will impact other general expectancies of ecigarettes. However, we are agnostic on whether the FDA PSA will produce generally more
negative expectancies (i.e., generalizing from the predicted negative health expectancy change)
or generally more positive expectancies (i.e., generalizing from the predicted potency expectancy
change). Measured expectancies include affect regulation, physical sensations, weight control,
taste, stimulation, and social impression.
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Hypothesis 2.2. It is hypothesized that main effects of media type will impact other
variables reflecting motivation to quit smoking (i.e., switch to vaping). These variables include
harmfulness/safety and efficacy of e-cigarettes for cessation relative to other nicotine-containing
products, satisfaction, craving reduction, and motivation to switch. We are once again agnostic
upon the direction of the impact.

Secondary Aims
Secondary Aim 1 Exploration of participant characteristics as moderators
Participant characteristics, baseline expectancies about e-cigarettes, and smoking
dependence will be further explored as moderator variables, as previous research and theory
indicate that these factors may influence response to e-cigarette use. In particular, age will be
tested as a moderator, given that younger participants have been shown in previous research to
have higher positive e-cigarette expectancies than older participants (Dave et al., 2019); thus, age
may moderate the effects of media type on specific and general expectancies, in addition to
switching motivation. Furthermore, given that the FDA has targeted younger viewers with their
advertisement campaign, younger participants may have been previously exposed to the PSA
used in this study. As such, prior exposure, independent of age, will also be considered as a
moderator variable. Lastly, participants’ trait impulsivity, as assessed by measures of lack of
premeditation and sensation seeking, previously shown to be significantly associated with risky
behavior, such as substance use (Cyders et al., 2014), will also be tested as a moderator.
Secondary Aim 2. Expectancies as mediators of Specific Aim 2
Outcome expectancies relevant to negative health consequences and potency will be
explored as mediators of the relation between media type and the dependent measure of
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switching motivation. Outcome expectancies relevant to negative health consequences and
potency will also be explored as mediators of the relation between media type and general
expectancies such as affect regulation and weight control, as previous research and theory have
found that smoking behavior is often maintained by these variables.
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METHOD
Using a between-subjects design with adult smokers who had limited experience with ecigarette use, all participants first watched a baseline neutral video. Participants were then
randomized such that approximately one half of the sample viewed an FDA anti-vaping youth
campaign PSA and the other half viewed a control video that was generally matched for
duration, arousal, and health harm, but absent of e-cigarette content. Dependent measures of
expectancies about e-cigarettes, harmfulness of e-cigarettes, effectiveness of e-cigarettes for
smoking cessation, and likelihood of switching from combustible to e-cigarettes were obtained
prior to and following the videos. The entire session was preprogrammed through Qualtrics and
presented remotely via Amazon’s MTurk platform. Analyses were then conducted to assess
whether the FDA PSA modified specific and general expectancies about e-cigarettes.
Sample Size
Sample size analyses were conducted using G-power (Faul, Erdfelder, Lang, & Buchner,
2007). It was determined that a sample size of 128 (64 per group) would be required for the
analysis to achieve power of .80 for detecting main effects among the 2 groups, with a medium
sized effect (f = .25) and a two-tailed alpha level of .05. Due to concerns about participants’ pass
rate of programmed attention checks used to promote data quality (see below), it was determined
that the sample size should be increased to 160 to account for any potential data quality issues.
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Participants
Participant recruitment occurred via Amazon’s Mechanical Turk (MTurk) platform such
that individuals who likely met eligibility requirements were assessed by a preliminary screening
survey presented on MTurk. Eligible participants were then contacted with an option to
participate (as an MTurk paid “worker” for $7.50) in an online survey about Media and Smoking
that would take approximately 30 min to complete. Interested participants (MTurk Workers)
completed the remote session after meeting eligibility criteria: 1) At least 24 years old; 2)
Current daily smoker (smoke at least 5 cigarettes per day); 3) Smoking history of at least 100
lifetime cigarettes; 4) Must have limited lifetime use of e-cigarettes (fewer than 30 occasions); 5)
No past 30-day use of e-cigarettes; and 6) Not currently using a nicotine replacement product or
other cessation product, such as a nicotine patch, nicotine gum, or pharmacotherapy. The lower
age limit of the sample for the present study was set to ensure participants would be well above
the age group targeted by the FDA for the campaign PSA. A study flow diagram detailing
participant recruitment and randomization can be seen in Figure 1.
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Mturk Screener Survey (n = 1186)

 Not meeting inclusion criteria (n =
980)
 Declined to participate
(n = 40)

Randomized (n =

Experimental
(n = 79)

166)

Control
(n = 87)

Analyzed (n = 75)
 Excluded (n = 4, incorrectly sent
main survey link though ineligible)

Analyzed (n = 86)
 Excluded (n = 1, incorrectly sent main
survey link though ineligible)

Figure 1. Study flow
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Baseline Measures
Baseline and Demographic Questionnaire. Participants completed questionnaires
capturing basic demographic information, smoking history, and vaping history. Questionnaires
pertaining to the individual’s expectancies about e-cigarettes and trait impulsivity were also
administered.
Expectancies about E-cigarettes . Participants’ expectancies about the effects of ecigarette use were measured with a modified version of the Smoking Consequences
Questionnaire-Adult (SCQ-A; Copeland, Brandon, & Quinn, 1995). On this scale, participants
were asked to consider the likelihood of a particular consequence on a scale of “0– completely
unlikely” to “9– completely likely.” The original questionnaire was developed to assess
expectancies about the reinforcing effects of cigarettes in adults, and the items load onto ten
factors: Negative Affect Reduction, Stimulation/State Enhancement, Health Risk,
Taste/Sensorimotor Manipulation, Social Facilitation, Weight Control, Craving/Addiction,
Negative Physical Feelings, Boredom Reduction, and Negative Social Impression. In the present
study, the highest loading item from each factor was included. All items were modified to ask
about vaping e-cigarettes instead of smoking combustible cigarettes. Additionally, questions
about satisfaction, stress reduction, and negative health consequences were added. Similar
modified versions have been effectively utilized in previous research to assess expectancies of ecigarette use in comparison to expectancies about cigarette smoking and NRT (Harrell et al.,
2015a) and showed good internal consistency in the current study (coefficient α = 0.87). Three
newly developed items to assess potency were also added: E-cigarettes produce powerful effects;
E-cigarettes can provide a strong dose of nicotine; Vaping produces powerful physical
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sensations. The three potency items showed acceptable internal consistency (coefficient α =
0.66) and the three negative health harm items showed good internal consistency (coefficient α =
0.78) in the current study.
Smoking Dependence. Cigarette dependence was measured with the Fagerström Test for
Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, & Fagerström, 1991), which was
included in the smoking history form. Scores on this measure range from 1-10, with higher
scores indicating greater dependence (α = 0.66).
Motivation to Quit Smoking. Motivation to quit was measured with the Contemplation
Ladder (Biener & Abrams, 1991), which was included in the smoking history form. The
contemplation ladder is a single-choice, visual analogue scales that depicts a ladder, such that
higher rungs represent greater levels of readiness to change.
Desire to Smoke. The desire to smoke was measured using a 3-item adaptation of the
Questionnaire of Smoking Urges-Brief (QSU). The QSU is a 10-item questionnaire that
measures desire and intentions to smoke based on relief of negative symptoms and anticipation
of positive effects (Cox, Tiffany, & Christen, 2001; Tiffany & Drobes, 1991). However, there is
evidence that an adaptation of this measure, which utilizes 3 items assessing urge to smoke, is
equally valid in measuring desire to smoke (Kozlowski, Pillitteri, Sweeney, Whitfield, &
Graham, 1996). In the present study, this shorter version was administered. For each item,
participants were asked to report the degree to which they agree with a particular statement from
“0 – strongly disagree” to “6 – strongly agree,” for a score range of 0-18. The modified version
in the present study showed excellent reliability (α = 0.91), as did the original version (α = 0.92).
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Affect. The maintenance of cigarette smoking can be partially attributed to affect
regulation (Brandon, 1994). Changes in affect in response to film clips as assessed by a singleitem measure of pleasant versus unpleasant on a 9-point Likert scale was previously shown to be
a valid and reliable measure of momentary state change (Gross & Levenson, 1995; Rottenberg,
Ray, & Gross, 2007). Participants were asked to report, in the present moment, the degree to
which they feel pleasant to unpleasant on nine-point Likert scale (0– “not at all” to 8–
“extremely”).
Trait Impulsivity/Proneness for Risky Behavior. Previous research has shown that trait
impulsivity is significantly associated with the initiation and maintenance of risky behaviors,
such as substance use (e.g., Cyders et al., 2014). Additionally, specifically concerning ecigarettes, increased impulsivity has been shown to be significantly associated with initiation and
use (e.g., Chivers et al., 2016; Grant et al., 2019). The UPPS-P Impulsive Behavior Scale, which
utilized the Five Factor Model of personality to elucidate the multi-faceted nature of impulsivity,
is comprised of 59 items that represent five factors (Lynam et al., 2006). Development and
validation of a shorter 20-item form, the SUPPS-P, was shown to retain the original factor
structure (Cyders et al., 2014). For the present study, eight items from the SUPPS-P that
represent two of the factors: (1) premeditation (α = 0.81) and (2) sensation seeking (α = 0.75)
were administered. These two scales were previously shown to have the strongest significant
association with risky behavior (Cyders et al., 2014). Participants were asked to report the
degree to which they agree with each item on a four-point Likert scale (1– “agree strongly” to 4–
“disagree strongly”).
Harmfulness of E-cigarettes. Participants were asked to rate the harmfulness of ecigarettes relative to combustible cigarettes and NRT on a harm continuum represented as

22

pictures with corresponding identification labels that included: combustible cigarette, e-cigarette
(First-, Second-generation products, and mod-pod device, such as Juul), pharmacotherapy (e.g.,
Chantix/varenicline), nicotine gum, and nicotine patch. Scores for each item ranged from “0 –
not at all harmful” to “100 – extremely harmful.”
Effectiveness of E-Cigarettes for Smoking Cessation. Participants were asked to rate
how strongly they believe each of four products (e-cigarette [e.g., First-, Second-generation
products, and mod-pod device, such as Juul), pharmacotherapy [e.g., Chantix/varenicline],
nicotine gum, and nicotine patch is effective for smoking cessation. Scores for each item ranged
from “0 – not at all effective” to “100 – extremely effective.”
Likelihood of Switching from Cigarettes to E-cigarettes. After viewing the video to
which they were assigned, participants were asked to estimate their likelihood to switch from
cigarettes to e-cigarettes by rating this possibility from “0 – not at all likely” to “10 – extremely
likely.”
Aversiveness of Video. If a participant had previously seen the video, there could have
been an effect of past exposure on affect elicitation, among other dependent variables.
Additionally, in an attempt to assess whether the videos elicited approximately equal disgust
between groups, a question was asked to rate the level. A questionnaire was administered to ask:
1) If the participant had ever seen the video previously; 2) If yes, approximately how many
times; 3) Rate the level of disgust from “0–not at all disgusting” to “10–extremely disgusting.”
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APPARATUS

Videos
First, all participants viewed a 30-s baseline video both to orient the participant to the
forthcoming task and to disguise the purpose of the experiment. The video was a general paper
towel commercial that is neutral to pleasant in tone. The video depicts parents chatting in a
kitchen, with the mother working on a computer. Next, a child dressed as a pirate enters and
lightheartedly scares the father by sneaking up with a pirate’s sword. Afterward, the father spills
his drink, and it approaches the mother’s computer. The paper towel is used to clean up the mess,
and the commercial closes with the father playfully chasing his pirate-dressed daughter.
Participants were then randomly assigned to view one of two 30-s videos, either the
FDA’s Real Cost of Vaping Campaign video, “Vaping is an Epidemic” PSA
(https://www.youtube.com/watch?v=zYuyS1Oq8gY), or a control non-e-cigarette video (an
abridged portion of Animal Planet’s Monsters Inside Me, Season 8, Episode 11, “My Lungs are
Rotting;” https://www.youtube.com/watch?v=7quwKQD_exM) that was generally matched for
duration, health harm, and disgust arousal.
Experimental video. The FDA PSA begins with the narrator stating that “an epidemic is
spreading” while showing teenaged girls with skin lesions that look like raised parasites. This is
followed by what is presumably the inside of the body with numerous parasites traveling
throughout. The PSA then alternates between showing internal parasites and external bodily
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lesions in the shape of these parasites on teenaged males’ bodies. The narrator then explains that
the epidemic releases chemicals throughout the bloodstream. Finally, the narrator explains that it
is not a parasite causing these harmful health issues, but rather, they are due to vaping. The PSA
closes with images of teenaged females and males using an e-cigarette that is similar to Juul.
Thus, attributing the parasite-like damage to the e-cigarette.

Control video. The control video shows a woman in a hospital gown who has numerous
skin lesions (similar in appearance to those in the FDA PSA), which the narrator states are due to
an infestation of parasites. The video then shows images of the roundworm, toxocara, including
showing the parasites within the human body as they move through the bloodstream. The
parasites are abundant within the body. The narrator explains that the parasites are attacking the
woman’s organs, and the body responds by forming patches of the rash over her body. The video
closes by stating that the woman likely contracted the parasite by eating tainted food.
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PROCEDURE
The order of the procedure and measures administered at each timepoint is summarized
in in the next page in Table 1.
MTurk Screening
Individuals, MTurk “workers,” were screened for eligibility via Amazon’s MTurk
platform via completion of a 10-question survey, for which the worker was paid $0.15,
independent of eligibility status. To combat the potential problem of individuals completing the
eligibility survey multiple times, IP addresses were screened, such that only the first submission
from an IP address was considered for eligibility and only unique Mturk worker IDs were
eligible for payment. There were no duplicate IP address occurrences and all submissions were
from unique worker IDs in the present study.
Qualified participants were then offered the opportunity to complete an approximately
30-min survey. Interested participants were then remotely directed via hyperlink to the Qualtrics
session. TurkGate, which is a web service that provides some useful functionality for running
MTurk experiments, was utilized to restrict the survey preview option, given that exposing
workers to parts of the survey prematurely (e.g., previews) may have invalidated results.
TurkGate also prevents workers from returning to a survey (even if they closed it accidentally).
Participants were then notified of compensation for completion of the survey ($7.50). As with
the eligibility survey, both IP addresses and Worker IDs were screened for duplicate
submissions; there were not duplicate occurrences of either in the present study.
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Table 1
Procedure order and measures administered
Procedure Order

Measures Administered

Mturk Screening Survey

Mturk Screening Questionnaire

Beginning of Session (Main Survey)

Informed Consent
Demographic and Smoking/vaping History
FTND
Contemplation Ladder
Modified SCQ-A
Harmfulness of E-cigarettes Questionnaire
Effectiveness of E-cigarettes for Smoking Cessation
Questionnaire
Affect Measure
SUPPS-P ([lack of] premeditation and sensation seeking subscales)
QSU

Baseline Video
Post Baseline Video

Affect Measure
Baseline Video Questionnaire

Experimental/Control Video
Post Video

Modified SCQ-A
Harmfulness of E-cigarettes Questionnaire
Effectiveness of E-cigarettes for Smoking Cessation
Questionnaire
Affect Measure
Likelihood of Switching and Video Questionnaire
Contemplation Ladder
QSU
Final Smoking Questionnaire

Compensation

Compensation Form

Consent. A consent form, which included a brief description of the study and explained
the purpose, risks, benefits, rights, and confidentiality of the study was first presented on a
screen. Participants were informed that this was a study of Media and Smoking to assess
smokers’ reactions to brief videos. By clicking a box labeled “I agree,” the main survey was then
initiated. If a participant clicked “I do not agree,” then the survey was terminated.
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Randomization. After electronically consenting to participate, participants then viewed
the baseline video. Afterward, a randomizer element within the Qualtics survey created a branch
such that participants were randomly assigned either to the FDA PSA or the control video;
hereafter, these conditions are referred to as experimental and control, respectively.

Administration of Baseline Questionnaires. Participants completed demographic and
baseline measures as follows: Demographic and Smoking/Vaping History Questionnaire, which
also included the FTND and Contemplation, Modified version of the SCQ-A, Harmfulness of Ecigarettes Questionnaire, Effectiveness of E-cigarettes for Smoking Cessation Questionnaire,
Affect Measure, SUPPS-P Impulsivity Behavior Scale (only two scales: [lack of] premeditation
and sensation seeking), and QSU.
Videos. First, participants were told that this was a study to assess smokers’ responses to
two brief (30 s) videos. Then, participants were shown the baseline video. Following the baseline
video, participants completed the following measures: Affect Measure and Video Questionnaire.
Participants then viewed the video to which they were randomized. Then the following
dependent measures were administered: Modified version of the SCQ-A, Harmfulness of Ecigarettes Questionnaire, Effectiveness of E-cigarettes for Smoking Cessation Questionnaire.
Additionally, the Likelihood of Switching to E-cigarettes Questionnaire was administered.

Inattention checks. To attenuate effects of nonadherence to instructions on data quality,
there were four inattention checks programmed within the session. The first inattention check
occurred at the end of the Smoking History Questionnaire, and it asked participants to select
which of the following specialty cigarette brands have they tried or none of the above. The five
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listed brands were devised for this study (Midnight Cowboy, Wild Llama, Fortunate Spare,
Wiltshire Lights, and Jamestown Menthol). To pass this inattention check, participants needed to
select “none of the above.” The second inattention check, which was an infrequency item from
the Attentive Responding Scale (ARS-18; Maniaci & Rogge, 2014) was embedded (item 5)
within the SUPPS-P, and it stated, “I’d rather be hated than loved.” Scores on this item of 3–
“disagree some” or 4–“disagree strongly” were considered as passing; whereas scores of 1–
“agree strongly” and 2–“agree some” were considered as failing the inattention check. The third
and fourth inattention checks occurred during the Baseline Video Questionnaire and Post-Video
Questionnaire, respectively. The item was the same for each, and it stated, “In 5 words or less,
what was this video about?” To pass the first of these checks, participants needed to mention at
least one of the following: paper towels, pirates, family, or spill. To pass the second, those who
viewed the FDA PSA needed to mention at least one of the following: e-cigarettes, epidemic,
vaping, parasite, or health harms/dangers of e-cigarettes. For participants who watched the
control video, they must have mentioned at least one of the following: rash, roundworm, parasite,
and/or toxocara. For both of the video inattention checks, any synonyms for the previously stated
words were also accepted as passing. Participants needed to pass 3 of the 4 inattention checks for
data to be included in analyses.

Compensation. On the last screen of the survey, participants were presented a
compensation form requesting their Worker ID. Upon verification of the participant’s
satisfactory pass rate of the inattention checks (see above), compensation of $7.50 was deposited
into the worker’s MTurk account within seven business days. All participants in the present
study met the attention check criterion for payment, and there were no occurrences of either
duplicate IP address or Worker ID.
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DATA ANALYSIS

To test group equivalence on demographics, nicotine dependence, and other baseline
variables, a series of chi-squares or analyses of variance (ANOVAs) were conducted, comparing
the two condition groups. Next, to test the hypotheses in Aims 1 and 2, condition groups were
compared using one-way ANOVA or analysis of covariance (ANCOVA; if a pre-test score was
used as a covariate).
Several expectancy and baseline characteristics were explored as moderators to evaluate
if participant characteristics affected the main effect of the video manipulation. Hierarchical liner
regression was used, entering the pre-test score (if applicable) as the first step, the manipulation
variable as the second step (video type), the moderator variable (expectancy variable,
dependence, motivation to quit, age, or gender) as the third step, and lastly, the moderator X
manipulation interaction. Post-hoc simple effects analyses were used to assess trends between
moderator variable groups. Finally, any significant differences in moderator groups were
followed up by exploratory comparisons of expectancies using independent samples t-tests.
Analysis of mediation was conducted using the PROCESS macro developed by Hayes
(2017). In these analyses, video type served as the independent variable, e-cigarette expectancy
ratings from either the three negative health harm or three potency items served as the mediator,
and effectiveness of e-cigarettes for smoking cessation or switching motivation was the outcome.
Additional mediation analyses were conducted on specific expectancies relevant to the outcome
variables. Statistical significance of the indirect (mediated) effect was estimated using 10,000
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bootstrapped samples and the 95% CI. Separate mediation analyses were conducted based either
on negative health harm or potency expectancies, as well as the specific expectancies tested.
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RESULTS

Participant Characteristics
Five participants were removed from final analyses (because they were inadvertently sent
a survey link despite not meeting eligibility criteria from the initial screening survey) for a final
sample size of 161. Two participants reported smoking during the study session. Removing their
data did not appreciably alter the results, so they were retained. Participant demographic and
smoking/vaping characteristics can be seen in Tables 2 and 3, respectively. Overall, the sample
was diverse and representative of the geographic area of recruitment. Participants’ trait
impulsivity, previously found to be significantly associated with substance use (e.g., Cyders et
al., 2014), including the initiation and maintenance of e-cigarette use (e.g., Chivers et al., 2016;
Grant et al., 2019) was measured, given that differences on this variable could have produced
confounds and/or moderation of subsequent comparisons between conditions. Measured by the
SUPPS-P, in which the minimum subscale score is 4 and the maximum is 16, the sample was
low on (lack of) premeditation (M: 6.60; SD: 2.14) and sensation seeking (M: 8.13, SD: 2.95).
Results from chi-squared tests and ANOVAs did not show any significant differences between
conditions on any demographic, smoking/vaping characteristic, or impulsivity variable.
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Table 2
Participant demographics (N=161)
Variable
Age
Gender

Race

Ethnicity
Marital Status

Sexual Orientation

Education

Income

Description
(range 25-75)
Male
Female
Transgender
American Indian / Alaska Native
Asian
Native Hawaiian / Pacific Islander
Black / African American
White / European Origin
Multiracial
Hispanic / Latino
Non-Hispanic
Single
Married/Domestic Partnership
Separated
Divorced
Widowed
Lesbian
Gay
Bisexual
Straight
Prefer not to answer
Other (pansexual)
Less than high school
High School
Some College
Tech School / Associate’s
4-year College Degree
Some school beyond 4-year degree
Beyond 4-year Degree / Professional
Degree
Under $10,000
$10,000 - $29,999
$30,000 - $49,999
$50,000 - $69,999
$70,000 - $89,999
Over $90,000

Note: No significant differences between conditions were found for any of the variables.
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Mean or N
49.3
56
104
1
2
5
0
14
136
4
7
154
32
88
2
31
8
0
3
8
149
0
1
2
42
51
32
25
4

% or SD
11.86
35%
65%
<1%
1%
3%
0%
9%
85%
2%
4%
96%
20%
55%
1%
19%
5%
0%
2%
5%
93%
0%
1%
1%
26%
32%
20%
16%
3%

5

3%

9
37
46
27
12
30

6%
23%
29%
17%
8%
19%

Table 3
Participant smoking and vaping characteristics
Variable
Cigarettes per day (Range 5-40)

Mean or N
14.9

% or SD
6.60

Reported years smoking

29.8

12.07

Reported past cigarette cessation attempt

130

81%

Reported past e-cigarette use

78

49%

FTND

4.7

2.16

Note: No significant differences were found between conditions on these variables.

Significant differences between conditions were found on one baseline variable (affect)
and two pre-test variables (e-cigarette expectancy for appetite control [measured by the modified
SCQ] and effectiveness of e-cigarettes for smoking cessation); these are shown in the leftmost
columns of Table 3. Concerning affect, those in the experimental group reported higher scores at
baseline, compared to the control group, F (1, 159) = 8.18, p < .01. Regarding the two significant
pre-test variables, compared to the control group, those in the experimental group reported lower
scores on both the e-cigarette expectancy item for appetite control, F (1, 159) = 6.48, p < .01,
and on the rating of effectiveness of e-cigarettes for smoking cessation, F (1, 159) = 6.94, p <
.01.
Furthermore, initial analyses revealed a floor effect, such that participants who rated the
effectiveness of e-cigarettes for smoking cessation as zero or one at baseline, rated all related
subsequent dependent variables as zero or one, respectively (e.g., likelihood of switching from
cigarettes to e-cigarettes). The slider scale on the survey defaulted to the value of one if a
participant clicked on the lowest end and did not manually move it leftward (to zero) from this
initial position, such that a score of one potentially could be functionally equivalent to zero. In
sum, there were 21 participants (14 in the experimental group and 7 in the control group) who
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showed this floor effect. Data from these participants contributed to heteroscedasticity and
nonnormality. Consequently, all data were analyzed for the full sample and for the subsample of
participants (n = 140) who did not show this floor effect (i.e., the effectiveness of e-cigarettes for
smoking cessation rating was greater than one at baseline). Data met assumptions of normality
and homogeneity of variance following removal of these participants from analyses.
The subsample, relative to the full sample, showed a smaller baseline difference in affect,
but the difference remained significant, F (1, 138) = 4.61, p < .05; however, there were no other
significant differences on baseline or pre-test variables, which are shown in the rightmost
columns of Table 4. Notably, the significant difference in affect was no longer present in the full
sample or subsample after participants viewed the baseline video, either when testing with
ANCOVA (to control for pre-test levels) or by ANOVA (Full Sample: F [1, 159] = 4.47, p = .50;
Experimental M = 5.37, SD = 1.85; Control M = 5.17, SD = 1.84; Subsample: F [1, 138] = .98, p
= .33; Experimental M = 5.36, SD = 1.7; Control M = 5.06, SD = 1.81). Accordingly, the
subsample groups viewed the video to which they had been assigned with no remaining
significant differences on key variables.
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Table 4
Significant baseline and pre-test variables between conditions
Full Sample

Subsample

Means
Variable
Appetite Control
(Modified SCQ
expectancy item)
Effectiveness of ECigarettes for Smoking
Cessation

Means

Experimental

Control

F

Experimental

Control

F

2.72

3.65

6.48*

3.02

3.75

3.65

28.79

40.02

6.94**

35.28

43.56

3.62

6.09

5.35

8.18**

5.93

5.33

4.61*

Affect

Note: * p < .05, ** p <.01. SCQ = Smoking Consequences Questionnaire (modified for e-cigarettes).

Affect and disgust elicitation. Between condition differences on the affect and disgust measures
were tested to assess whether the FDA and control videos elicited equivalent levels of each. As
seen in Table 5, there were no between condition differences on affect (controlling for pre-test
levels) or disgust. Had these affective experiences differed in response to the videos, it could
have produced confounds for subsequent comparisons between conditions.

Table 5
Manipulation effects on posttest affect and disgust elicitation, with and without adjusting for premanipulation values.

Variable

Means
Exp. Control

Full Sample
Adjusted
Means
Exp. Control
F

Affect

2.23

1.49

5.04*

2.11

1.61

2.32

2.31

1.53

4.79*

2.17

1.63

2.51

Disgust

5.75

6.23

1.66

--

--

--

5.72

6.29

2.23

--

--

--

F

Note: * p < .05. -- = no pre-test covariate adjustment. Exp. = Experimental.
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Means
Exp. Control

Subsample
Adjusted
Means
Exp. Control
F

F

Aim 1
We first tested specific health harm and potency expectancies hypothesized to be affected
by the video manipulation. As seen in Table 6, participants who viewed the FDA PSA reported
greater e-cigarette health harm expectancies (controlling for pre-test levels) compared to those
who viewed the control video, F (1, 158) = 10.04, p < .01 (full sample), F (1, 137) = 11.60 p <
.001 (subsample). A similar effect was found for potency expectancies, F (1, 158) = 17.28, p <
.001 (full sample), F (1, 137) = 10.80 p < .01 (subsample). Additionally, we found that the
health harm and potency scales were positively correlated in both the full sample at pre-test,
r(159) = .38, p < .001, and post-test, r(159) = .48, p < .001, and in the subsample at pre-test,
r(138) = .40, p < .001, and post-test r(138) = .51, p < .001.
For both the full sample and subsample, age, gender, nicotine dependence (measured by
the FTND), impulsivity (measured by the SUPPS-P [lack of] premeditation and sensation
seeking subscales), and prior exposure to the video were tested as moderators of these
expectancy effects. No moderation was found.

37

Table 6
Manipulation effects on posttest modified SCQ – E-cigarette expectancies, with and without
adjusting for pre-manipulation values
Full Sample
Means
Variable

Exp.

Health
Harms

21.8
7
16.7
1

Potency
Affect
Regulation

Control

Subsample

Adjusted Means
F

20.47

2.52

14.58

2.2

3.37

Stimulation
Concentratio
n
Boredom
Reduction

1.59

2.57

5.35*
9.47*
*
8.66*
*

1.8

2.65

3.01

3.94

Taste
Weight
Control
Sociability
Negative
Physical
Sensations
Negative
Social
Impression
Vaping
would be
Satisfying
Satisfy
Nicotine
Craving

2.73

3.81

2.25
1.24

Exp.

22.1
0
16.9
1

Means

Control

20.42
14.41

F

10.04**
17.28**
*

Exp.

21.3
9
16.6
2

Control

F

20.11

1.75

14.75

Adjusted
Means
Contro
Exp.
l

21.7
1
16.7
4

F

19.90

11.63**
*

14.66

10.81**

2.49

3.46

2.41

3.52

2.43

7.58**
17.84**
*

3.99*
7.39*
*

1.75

2.67

6.25*

1.85

2.59

15.8***
17.39**
*

1.99

2.49

6.41*

2.05

2.78

3.85

2

2.71

4.25*

3.31

3.68

1.83

3.25

4.15

3.38

4.04

5.38*

3.17

3.43

1.55

3.05

3.97

3.4
5.06*
*

3.41

3.70

1.59

3.31
1.76

4.08*
7.62*
*
9.13*
*
2.37

2.62
1.50

3.00
1.52

2.66
.02

2.54
1.30

3.42
1.87

5.45*
2.59

2.84
1.55

3.18
1.68

1.81
.65

6.17

5.56

2.61

6.26

5.48

12.14**
*

5.90

5.42

1.42

6.06

5.31

9.23**

3.52

4.00

1.16

3.85

3.71

.27

3.75

4.03

.36

3.96

3.87

.36

2.25

3.26

6.61*

2.45

3.08

7.91**

2.57

3.44

4.33*

2.69

3.36

6.97**

3.32

4.44

7.28*
*

3.65

4.16

7.28**

3.64

4.62

5.27*

3.9

4.42

4.12*

2.92

3.57

1.75

6.09*

Note: * p < .05, ** p < .01, *** p < .001. Exp. = Experimental. Modified SCQ = Smoking Consequences Questionnaire (modified for ecigarettes).

Aim 2
Positive Expectancies. We next tested if the positive expectancy variables presented in
Hypothesis 2A were affected by the video manipulation. As seen in Table 6, participants who
viewed the FDA PSA reported lower e-cigarette positive expectancies (controlling for pre-test
levels) compared to those who viewed the control video for affect regulation (F [1, 158] = 7.58,
p < .01 [full sample], F [1, 137] = 15.80 p < .001 [subsample]), stimulation (F [1, 158]= 17.84, p
< .001 [full sample], F [1, 137] = 17.39, p < .001 [subsample]), and concentration (F [1, 158)]=
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6.41 p < .05 [full sample], F [1, 137] = 4.25 p < .05 [subsample]). Additionally, participants in
the subsample who viewed the FDA PSA reported lower boredom reduction expectancies than
those who viewed the control video, F (1, 137) = 5.38 p < .05. Results revealed no group effects
on taste, weight control, or sociability.
Negative Expectancies. Shown in Table 6, participants who viewed the FDA PSA
reported higher e-cigarette negative physical sensation expectancies than did those who viewed
the control video, F (1, 158) = 12.14, p < .001 (full sample), F (1, 137) = 9.23, p < .01
(subsample). No significant differences were found on negative social impression.
Expectancies Related to Switching to E-Cigarettes. We tested group differences in
expectancies reflecting motivation to switch from combustible to e-cigarettes. As seen in Table
6, participants who viewed the FDA PSA reported lower e-cigarette satisfaction expectancies
(“E-cigarettes would be satisfying”) compared to those who viewed the control video, F (1, 158)
= 7.91, p < .01 (full sample), F (1, 137) = 11.33 p < .001 (subsample). A similar effect was
found for nicotine craving expectancies (“Vaping would satisfy my nicotine cravings”), F (1,
158) = 17.28, p < .001 (full sample), F (1, 137) = 10.80 p < .01 (subsample).
Harmfulness of E-cigarettes. Subsequently, harmfulness ratings of e-cigarettes relative
to cigarettes and smoking cessation aids, including nicotine patches, nicotine gum, and smoking
cessation medications were tested. As seen in Table 7, participants who viewed the FDA PSA
reported greater harmfulness ratings of e-cigarettes compared to those who viewed the control
video, F (1, 158) = 12.45, p < .001 (full sample), F (1, 137) = 14.5, p < .001 (subsample).
Notably, we did not find group differences on harmfulness ratings of any of the other products.
When comparing harmfulness ratings of products individually, Welch two-sample t-tests
revealed that e-cigarettes were rated at baseline (full sample M: 77.99; subsample M: 75.69) by
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both condition groups as significantly more harmful than all tested cessation aids (nicotine gum:
full sample M: 26.50, t[317.78] = 20.88, p < .001; subsample M: 25.70, t[271.83] = 19.02, p <
.001; nicotine patches: full sample M: 27.89, t[319.95] = 19.39, p < .001; subsample M: 27.73,
t[276.64] = 17.78, p < .001; smoking cessation medications: full sample M: 33.91, t[312.92] =
15.58, p < .001; subsample M: 32.84, t[276.55] = 14.64, p < .001). However, e-cigarettes were
rated at baseline by both groups as significantly less harmful than combustible cigarettes (full
sample M: 87.59, t[257.77] = -14.43, p < .001; subsample M: 86.92, t[240.34] = -15.93, p <
.001). Following the video manipulation, those who viewed the FDA PSA no longer rated ecigarettes (full sample M: 87.07; subsample M: 85.41) as significantly different in harmfulness
from combustible cigarettes (full sample M: 89.95, t[130.97] = -1.12, p = .26; subsample M:
82.23, t[103.99] = -1.33, p = .19), whereas those who watched the control video continued to rate
e-cigarettes (full sample M: 77.97; subsample M: 76.27) as significantly less harmful than
combustible cigarettes (full sample M: 88.52, t[127.81] = -3.98, p < .001; subsample M: 87.94,
t[137.72] = -3.87, p < .001). As occurred at baseline, following the video manipulation, both
groups continued to rate e-cigarettes as significantly more harmful than the tested smoking
cessation aids.
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Table 7
Manipulation effects on posttest harmfulness ratings, with and without adjusting for premanipulation values

Full Sample
Means
Variable

Exp.

Control

E-cigarette
Nicotine
Gum

87.07

77.97

26.95

Cigarette
Nicotine
Patch
Cessation
Medications

Subsample

Adjusted Means
Exp.

Control

8.00**

86.23

78.69

25.05

0.29

26.68

89.95

87.91

0.88

31.51

29.53

37.61

30.22

Means
Exp.

Control

14.50***

85.41

76.27

25.28

0.67

25.54

88.91

88.81

0.92

0.26

30.57

30.35

3.43

34.45

32.96

F

Adjusted Means
Exp.

Control

6.63*

84.97

76.61

14.20***

24.57

0.08

25.41

24.67

0.18

89.28

87.94

0.31

88.68

88.39

0.06

0.01

30.43

29.51

0.05

29.78

30.01

0.011

0.61

37.11

29.44

0.06

33.84

31.97

0.78

F

F

F

Note: * p < .05, ** p < .01, *** p < .001. Exp. = Experimental

`

Effectiveness of E-cigarettes for Smoking Cessation. We next compared groups on

their ratings of effectiveness of e-cigarettes for smoking cessation relative to the same alternative
smoking cessation aids. As seen in Table 8, participants who viewed the FDA PSA reported
lower effectiveness ratings of e-cigarettes for smoking cessation compared to those who viewed
the control video, F (1, 158) = 8.65, p < .01 (full sample), F (1, 137) = 7.78, p < .01 (subsample).
There were no significant ratings differences between condition groups for the other cessation
products. Results are plotted for the full sample and the subsample in Figure 2a and 2b,
respectively. Subsequently, a factorial ANOVA was conducted to examine the effect of
condition group (experimental and control) and smoking cessation product (nicotine gum, ecigarette, nicotine patch, and cessation medications) on ratings of effectiveness for smoking
cessation. The group X product interaction did not reach statistical significance in either the full
sample, F (3, 636) = 2.14, p = .09 or the subsample, F (3, 552) = 2.11, p = .10.

41

Table 8
Manipulation effects on posttest effectiveness for smoking cessation ratings, with and without
adjusting for pre-manipulation values.

Full Sample
Means
Variable

Exp.

ECigarettes
Nicotine
Gum
Nicotine
Patch
Smoking
Cessation
Medication
s

22.5
3
39.8
1

Control

Subsample

Adjusted Means

F

Exp.

39.33

15.45**
*

43.02

0.7

22.5
3
42.4
8

45.8

52.02

2.57

50.3
3

60.44

6.35*

Means

Control

F

Exp.

39.33

8.65*
*

40.7

0.58

48.7

49.5

0.17

27.5
4
40.7
5
47.3
4

53.6
6

57.54

2.55

52.3
4

Control

Adjusted Means

F

Exp.

42.56

10.96*
*

41.66

0.049

50.71

0.68

31.1
7
42.7
2
48.6
7

59.95

3.18

54.2
7

Control

F

39.76

7.78*
*

40.14

1.11

49.69

0.22

58.46

2.52

Note: * p < .05, ** p < .01, *** p < .001. Exp. = Experimental.

Switching Motivation from Combustible to E-cigarettes. Participants randomized to
the FDA PSA reported lower likelihood of switching (i.e., switching motivation) from
combustible to e-cigarettes (full sample M = 3.65; subsample M = 4.48) than those who viewed
the control video (full sample M = 14.35; subsample M = 15.62), F (1, 159) = 18.37, p < .001
(full sample), F (1, 138) = 15.58, p < .001 (subsample). Results for the full sample and
subsample are plotted in Figure 3a and 3b, respectively.
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Figure 2a. Manipulation effects on posttest effectiveness for smoking cessation ratings upon the
full sample, with adjusting for pre-manipulation values
Note. ** p < .01. Scores presented are adjusted by respective pre-test scores. Error bars are standard

error of the

mean.

Figure 2b. Manipulation effects on posttest effectiveness for smoking cessation ratings upon the
subsample, with adjusting for pre-manipulation values.
Note. ** p < .01. Scores presented are adjusted by respective pre-test scores. Error bars are standard
error of the mean.

43

Figure 3a. Manipulation effects on switching motivation from combustible to e-cigarettes upon
the full sample.
Note. *** p < .001. Error bars are standard error of the mean.

Figure 3b. Manipulation effects on switching motivation from combustible to e-cigarettes upon
the subsample.
Note. *** p < .001. Error bars are standard error of the mean.
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Motivation to Quit Smoking. With respect to overall motivation to quit smoking as
measured by the Contemplation Ladder, we found no differences between experimental
conditions for either the full sample or subsample (see Table 9). Notably, this variable was the
only one for which we had missing data; 23 participants did not complete this measure. Thus,
analyses were conducted with 138 participants’ data in the full sample (63 in the Experimental
condition and 75 in the Control) and 136 in the subsample (62 in the Experimental condition and
74 in the control). This missingness was likely due this particular measure differing from the
others in response instructions.

Table 9
Manipulation effects on posttest Contemplation Ladder – motivation to quit smoking, with and
without adjusting for pre-manipulation values
Full Sample (n = 138)
Adjusted
Means

Means
Variable

Exp.

Control

Contemplation
Ladder

5.41

5.05

Subsample (n = 136)

F

0.74

Adjusted
Means

Means

Exp.

Control

5.33

5.12

F

2.64

Exp.

Control

5.35

5.03

F

0.53

Exp.

Control

5.17

5.15

F

0.04

Note: Exp. = Experimental.

Urge to Smoke. On urge to smoke, measured by the QSU, those in the full sample who
watched the FDA PSA reported lower urges (controlling for pre-test levels) than those who
viewed the control video, F (1, 158) = 7.12, p < .01, but the difference did not appear in the
subsample (see Table 10).
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Table 10
Manipulation effects on posttest QSU – Urge to smoke, with and without adjusting for premanipulation values
Full Sample
Means
Variable

Exp.

Control

QSU

7.58

10.09

Subsample

Adjusted
Means
F
7.74**

Exp.

Control

8.21

9.54

Adjusted
Means

Means
F
7.12**

Exp.

Control

7.66

10.04

F
6.34*

Exp.

Control

8.45

9.43

F
3.56

Note: ** p < .01. Exp. = Experimental. QSU – Questionnaire of Smoking Urges – Brief urge factor.

Mediation Analyses
First-order correlations were calculated using post-manipulation scores of potential
mediators and key dependent variables (effectiveness of e-cigarettes for smoking cessation and
switching motivation). As shown in Table 11, effectiveness of e-cigarettes for smoking cessation
was most strongly positively correlated with positive expectancies (affect regulation, satisfaction,
craving reduction, and stimulation) and most negatively correlated with harmfulness of ecigarettes. A similar pattern was seen for the dependent variable of switching motivation. The
same pattern of results was found for the subsample.
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Table 11
First-order correlations of key dependent variables among the full sample.
Variable

1.

2.

3.

4.

5.

6.

7.

8.

9.

1. Health Harms (SCQ)

1

2. Potency (SCQ)
3. Affect Regulation
(SCQ)

.44***

1

-.05

.28***

1

4. Satisfying (SCQ)
5. Nicotine Craving
Reduction (SCQ)

-.05

.20*

.82***

1

.02

.34***

.75***

.74***

1

6. Stimulation (SCQ)
7. Negative Physical
Sensations (SCQ)

-.06

.35***

.78***

.7***

1

.52***

.31***

-.19*

.72***
.29***

-.12

-.14

1

8. Harmfulness
9. Effectiveness for
Smoking Cessation
10. Switching
Motivation

.71***

.25**

-.24**

-.23**

-.23**

-.20*

.52***

1

-.30***

.01

.49***

.46***

.43***

.43***

-.24**

-.36***

1

-.22**

.04

.47***

.50***

.38***

.41***

-.20*

-.39***

.46***

10.

1

Note: *** p < .001 ** p < .01. * p < .05. Exp. = Experimental. SCQ = Smoking Consequences Questionnaire (modified for e-cigarettes).

A series of mediation analyses was then conducted; video type served as the independent
variable and effectiveness of e-cigarettes for smoking cessation and switching motivation served
as the outcomes. The mediation models shown in Figure 4 were tested in the full sample and in
the subsample using post-manipulation scores of each potential mediator. For the outcome
variable of effectiveness of e-cigarettes for smoking cessation, shown in Table 12, the
bootstrapped analyses revealed a statistically significant indirect (mediated) effect in the full
sample and subsample of affect regulation (full sample: β = 6.55; 95% CI = 2.01-10.43;
subsample: β = 5.92; 95% CI = 1.41-10.10), satisfaction (full sample: β = 5.69; 95% CI = 1.168.74; subsample: β = 3.95; 95% CI = .22-7.76), nicotine craving reduction (full sample: β = 5.05;
95% CI = 1.05-8.63; subsample: β = 4.17; 95% CI = .56-7.91), stimulation (full sample: β =
5.50; 95% CI = 1.45-8.82; subsample: β = 4.68; 95% CI = .86-8.28), and harmfulness of e47

cigarettes (full sample: β = 4.37; 95% CI = 1.01-7.37; subsample: β = 3.47; 95% CI = .43-6.24).
However, the direct effect of video on effectiveness remained statistically significant when each
mediator was considered. These findings indicate that each of the aforementioned variables
mediated a portion of the relationship between video and effectiveness of e-cigarettes for
smoking cessation. The nature of the partially mediated relationships was that lower scores on
affect regulation (full sample: β = 5.60, p < .001; subsample: β = 5.33, p < .001), satisfaction
(full sample: β = 5.17, p < .001; subsample: β = 4.54, p < .001), nicotine craving reduction (full
sample: β = 4.51, p < .001; subsample: β = 4.25, p < .001), and stimulation (full sample: β =
5.61, p < .01; subsample: β = 5.09, p < .01) were associated with lower scores on effectiveness of
e-cigarettes. Alternatively, higher scores on harmfulness (full sample: β = -.88, p < .001;
subsample: β = -.38, p < .001) were associated with lower scores on effectiveness. The same
pattern of results was found for the outcome variable of switching motivation, shown in Table
13.

Figure 4. Mediation models tested.
Note: a = path from video (IV) to mediator. b = path from mediator to outcome variable. c = total effect of IV on outcome
variable. c’ = direct effect of IV on outcome variable. SCQ = Smoking Consequences Questionnaire (modified for e-cigarettes).
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Table 12
Mediation analyses on the dependent variable of effectiveness of e-cigarettes for smoking
cessation

Mediator
Health
Harms
(SCQ)
Potency
(SCQ)
Affect
Regulation
(SCQ)
Satisfaction
(SCQ)
Nicotine
Craving
(SCQ)
Stimulation
(SCQ)
Physical
Sensations
(SCQ)
Harmfulness
of
E-Cigarettes

a

Full Sample
Unstandardized
95% CI
Coefficients
b
c'
ab Lower Upper

a

Subsample
Unstandardized
95% CI
Coefficients
b
c'
ab Lower Upper

-1.4

1.53***

14.88**

2.14

-0.63

4.82

-1.23*

-1.24

13.61**

1.53

-0.83

4.29

-2.13*

0.07

17.51***

0.15

-2.57

1.03

-1.88
*

0.1

15.64**

0.19

-2.49

1.25

1.17**

5.60***

10.84*

6.55

2.01

10.43

1.11**

5.33***

9.60*

5.92

1.41

10.1

1.10*

5.17***

12.09**

5.69

1.16

8.74

.87*

4.54***

11.41*

3.95

0.22

7.76

1.12**

4.51***

12.26**

5.05

1.05

8.63

.98*

4.25***

11.26*

4.17

0.56

7.91

.98**

5.61**

11.89**

5.5

1.45

8.82

.92*

5.09**

10.82*

4.68

0.86

8.28

-0.62

-2.75**

15.35***

1.71

-0.34

4.01

-0.5

-1.93*

14.23**

0.97

-0.64

3.08

9.10**

-.48***

13.01**

4.37

1.01

7.37

-9.14*

-.38***

12.09**

3.47

0.43

6.24

Note: *** p < .001 ** p < .01. * p < .05. a = path from video (IV) to mediator. b = path from mediator to effectiveness of e-cigarettes for
smoking cessation (DV). c’ = direct effects. ab = indirect (mediated) effects. SCQ = Smoking Consequences Questionnaire (modified for ecigarettes). Total effects (c path) for the full sample: β = 16.80*** and the subsample: β = 15.02**.

Table 13
Mediation analyses on the dependent variable of switching motivation

Mediator
Health
Harms
(SCQ)
Potency
(SCQ)
Affect
Regulation
(SCQ)
Satisfaction
(SCQ)
Nicotine
Craving
(SCQ)
Stimulation
(SCQ)
Physical
Sensations
(SCQ)
Harmfulness
of
E-Cigarettes

a

Full Sample
Unstandardized
95% CI
Coefficients
b
c'
ab Lower Upper

a

Subsample
Unstandardized
95% CI
Coefficients
b
c'
ab Lower Upper

-1.4

-.66**

9.92***

0.92

-0.3

2.1

-1.23*

-.60*

10.51**

0.74

-0.5

1.97

-2.13*

0.11

11.30***

0.21

-1.98

0.2

-1.88
*

0.44

11.74***

0.83

-2.19

0.34

1.17**

3.16***

7.41**

3.7

1.2

5.93

1.11**

3.34***

7.84**

3.71

0.93

6.23

1.10*

3.32***

7.67**

3.62

0.67

5.87

.87*

3.44***

8.41**

3.01

0.19

5.81

1.12**

2.34***

8.44**

2.62

0.51

4.57

.98*

2.54***

9.00**

2.49

0.36

4.68

.98**

3.16***

8.00**

3.1

0.78

5.22

.92*

3.19***

8.59**

2.94

0.55

5.21

-0.62

-1.41**

10.00***

0.87

-0.16

2.02

-0.5

-1.26*

10,65***

0.63

-0.44

1.78

9.10**

-.31***

8.29**

2.81

0.67

4.58

-9.14*

-.29***

8.87**

2.65

1.05

4.58

Note: *** p < .001 ** p < .01. * p < .05. a = path from video (IV) to mediator. b = path from mediator to effectiveness of e-cigarettes for
smoking cessation (DV). c’ = direct effects. ab = indirect (mediated) effects. SCQ = Smoking Consequences Questionnaire (modified for ecigarettes). Total effects (c path) for the full sample: β = 10.70*** and the subsample: β = 11.14***.
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DISCUSSION
A great deal of controversy surrounds e-cigarettes, with some arguing that protection of
youth and non-users is paramount and others maintaining that these products are beneficial from
a harm reduction perspective for use by adult smokers for switching from combustible cigarettes
and for smoking cessation (Balfour et al., 2021). To advance the agenda of the former, opponents
of e-cigarettes have allocated tremendous expenditures toward the production of advertising
campaigns aimed at youth deterrence; however, to date, the effects of these ads upon adult
smokers has yet to be examined. In the present study, a between-subjects experimental design
was utilized to investigate the effects of an FDA-distributed youth-targeted anti-vaping PSA
upon adult smokers who view it. In an attempt to elucidate whether viewing this PSA would
impact adult smokers’ interest in using e-cigarettes for smoking cessation (i.e., switching
motivation), a number of outcome variables were tested.
It was hypothesized that the FDA PSA—compared to a matched control video absent of
e-cigarette content—would increase negative health-related expectancies, and, because the PSA
conveys that e-cigarettes are very powerful, it would also increase positive expectancies
concerning the potency of e-cigarettes. We observed that viewing the FDA PSA, relative to the
control video, produced increases in both health harm and potency expectancies.
Additionally, we hypothesized that the anti-vaping PSA would impact other general
expectancies of e-cigarettes and additional variables reflecting motivation to quit smoking (i.e.,
switch to vaping); however, we were agnostic concerning the direction of the impact. We found
that viewing the FDA PSA produced lower positive expectancies related to affect regulation,
50

stimulation, concentration, and, within the subsample, boredom reduction. Also, we found that
participants who viewed the FDA PSA reported higher e-cigarette negative physical sensation
expectancies. Concerning expectancies relevant to motivation to quit smoking, we found that
those who viewed the FDA PSA rated expectancies for e-cigarette satisfaction and nicotine
craving reduction lower compared to those who viewed the control video. Contrary to our
hypotheses, the observed increased potency expectancies did not generalize to more positive
expectancies. Rather, viewing the FDA PSA resulted in overall more negative expectancies
about e-cigarettes, which is consistent with our hypothesis that the predicted negative health
expectancy change would generalize to other expectancies. Additionally, the negative health
harm and potency expectancies were found to be positively correlated, so there likely was an
overall stronger negative impact stemming from the combined effects of negative health harm
and potency expectancies.
Furthermore, even though those who watched the FDA PSA rated e-cigarettes as
significantly less harmful than combustible cigarettes at baseline, they rated e-cigarettes and
combustible cigarettes as comparably harmful post-manipulation. Moreover, those who viewed
the FDA PSA rated e-cigarettes as less effective for smoking cessation. Additionally, they rated
e-cigarettes as the least effective cessation product when compared to nicotine gum, nicotine
patches, and smoking cessation medications. Lastly, viewing the FDA PSA resulted in lower
switching motivation. Therefore, our findings show that adults smokers who view the FDA PSA
would be less likely to consider e-cigarettes for smoking cessation.
The outcome variables of effectiveness of e-cigarettes for smoking cessation and
switching motivation were observed to be partially mediated by positive expectancies including
affect regulation, satisfaction, nicotine craving reduction and stimulation, such that lower scores
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on these expectancy variables were associated with lower scores on both outcomes. Additionally,
partial mediation was found with harmfulness of e-cigarette ratings, such that higher scores on
this mediator variable was associated with lower scores on both outcomes. Thus, these mediator
variables were found to mediate a portion of the relationship between the video and each
outcome variable. These mediational findings add to previous correlational analyses showing
associations between positive e-cigarette expectancies and smoking cessation (Harrell et al.,
2015).
Motivation to quit smoking
With respect to the overall motivation to quit smoking, measured by the Contemplation
Ladder, we found no differences between conditions. However, this is the only measured
variable for which we had missing data. Given that twenty-three participants did not complete
this measure, we may not have captured overall changes on this measure. Furthermore, this
measure may not be sensitive enough to capture small changes in motivation occurring over such
a brief duration.
Urge to Smoke
Psychological factors, such as negative affect, can influence desire to smoke (Baker et al.,
2004). In this study, those who viewed the control video reported higher urges to smoke, relative
to those who viewed the FDA PSA, measured by the QSU. The FDA and control videos were
found not to produce any between-group differences in affect or disgust elicitation; thus, this
difference in urge to smoke likely is not attributable to affect regulation. Rather, the lower urges
reported by those who viewed the FDA PSA could be attributable to a tarnishing effect in which
negative messages about one product, such as e-cigarettes, generalize to another, such as
cigarettes (Grummon et al., 2020). Accordingly, consistent with past research finding support for
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this tarnishing effect (Brewer et al., 2019; Gummon et al., 2020), anti-vaping advertising may
make both e-cigarettes and combustible cigarettes unappealing. However, the duration of this
tarnishing effect is unknown. Consequently, when an urge reemerges, it could be that those who
are exposed to this negative e-cigarette messaging may be less likely to utilize a product shown
to be beneficial for smoking cessation and less harmful than combustible cigarettes. Fortunately,
the PSA did not appear to cause this tarnishing effect with respect to the other smoking cessation
products, including the other nicotine delivery products (NRT). Consequently, smokers may be
more inclined to use these other methods.
Public Health Implications
The purpose of the present study was to assess whether public health campaigns designed
to scare youth away from vaping may have unintended consequences for adults who are exposed
to these ads and other materials, such that the negative messaging may ultimately deter adult
smokers from switching to a safer product and effective aid for smoking cessation (Abrams et
al., 2018; Beaglehole et al., 2019). Results showed that adult smokers’ exposure to an FDAdistributed youth-targeted anti-vaping PSA produced lower scores on all variables relevant to
harm reduction (i.e., switching from combustible to e-cigarettes), compared to viewing a control
video. In terms of public health, our results suggest that anti-vaping youth campaigns could
ultimately produce the opposite effects that Dave et al. (2019) and Kim et al. (2015) found with
e-cigarette advertisements, previously shown to increase motivation to quit smoking.
These unintended consequences seemingly occurred, at least in part, via modification of
adults’ expectancies about e-cigarettes, and the generalization of those expectancies to other
aspects of e-cigarettes, such as their potential for smoking cessation. Specifically, the negative
information about e-cigarettes conveyed in the PSA decreased positive expectancies and
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increased negative expectancies about them. These changes in expectancies then extended to
reduced beliefs about their efficacy as a smoking cessation aid and increased beliefs about their
harmfulness. In turn, these changes directly discourage their use for smoking cessation, given
that they are seen as ineffective as a smoking cessation aid and as harmful as combustible
cigarettes. In sum, youth-targeted anti-vaping campaigns may have deleterious effects for adult
smokers who might otherwise consider switching to e-cigarettes, potentially as a means to
discontinue nicotine use overall. Moreover, to date, no data have been provided by the FDA
showing that these advertisements are effective at their purported goal of youth deterrence. Thus,
the net public health impact of the messages is unknown.
Limitations
The results of this study should be considered within the context of several
methodological issues. First, the extent to which participants attended to the videos and survey
questionnaires is unknown. Although all participants passed the attention check criterion for data
to be included in analyses, 4% of the sample failed the attention check question that was
embedded within a questionnaire (as opposed to being a text box or stand-alone question).
Additionally, if the study were conducted in the laboratory, participants would not have had
access to alternative sources of distraction, including smoking (two participants endorsed having
done so, but the total remains unknown), as they would have in a home setting. Second, the null
moderation findings must be addressed. It is likely the case that the study was underpowered to
detect significant interactions.
Although the effect sizes of the video manipulation appear modest, it is important to
recognize that these effects emerged from a single exposure to the FDA PSA. In the real world,
individuals are likely to see the PSA multiple times with possible cumulative effects. Finally,
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limitations from the design of the experiment and the data analysis should be addressed. The ecigarette expectancy scales (SCQ) used in this study were adapted from cigarette questionnaires,
and they have not yet been validated for e-cigarettes. Moreover, the potency items that were
added have not been previously utilized or assessed for psychometric properties in combination
with the other items. Additionally, some scales were composed of a single-item (e.g., negative
social impression), which limits the ability to assess internal-consistency reliability and
potentially limits their validity. These measurement issues could have also impacted the
mediation analyses such that we may not have adequately captured variables that fully mediate
the relation between the video and outcome variables. Results from this study should be
interpreted in light of these considerations.
Conclusions
This study utilized a between-subjects experimental design to test the effects of an FDAdistributed youth-targeted anti-vaping PSA upon adult smokers. Findings indicated that a single
exposure to the PSA had the presumably unintended consequence of deterring adult smokers
from the likelihood of using a safer alternative (i.e., switching from combustible to e-cigarettes).
Consequently, these ads could have the net effect of maintaining smoking behavior. Although
the current study identified changes in vaping expectancies and intentions via a controlled study
with high internal validity, complementary naturalistic research is needed to quantify the effect
upon adult smokers exposed to this ad and other anti-vaping messaging in their daily lives. The
study demonstrates the importance of considering all potential audiences of, and their reactions
to, public health campaigns – particularly ones with alarmist messaging and images, such as the
FDA’s ad studied in this experiment. Surveys have found that the public tends to overestimate
the risks of vaping compared to smoking (Brose et al., 2015; Majeed et al., 2017; Malt et al.,
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2020), most likely based on asymmetrical media reports and public health campaigns that
prioritize discouraging vaping onset among youth. Future policy should attend to the full public
health impact of these messages.
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